Evidence map›Paper›PMID 20510935›Full record

ArticleAnalytical biochemistry2010

A versatile approach to transform low-affinity peptides into protein probes with cotranslationally expressed chemical cross-linker.

Aiko Umeda, Gabrielle Nina Thibodeaux, Kathryn Moncivais, Faqin Jiang, Zhiwen Jonathan Zhang

Open access · greenAbstract read
In one paragraph

Article in Analytical biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Aiko UmedaInstitute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA.
Gabrielle Nina Thibodeaux
Kathryn Moncivais
Faqin Jiang
Zhiwen Jonathan Zhang
The University of Texas at Austin · US

Funding

Regulation of structure and function of protein by glycosylationR01CA120168 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI ZHANG, ZHIWEN JONATHAN · 2008 to 2011
$1.0M
NCI NIH HHS R01 CA120 168NCI NIH HHS R01 CA120168
6 · The paper itself

Abstract

The potential usefulness of artificially selected peptides as probes to detect specific proteins has been proposed because of the ease and low cost of syntheses, manipulation, and genetic expression. However, the affinities of these peptides to their target proteins are generally too low to be practical as diagnostic or bioanalytical reagents. One approach to this problem is to incorporate a redox-active amino acid, 3,4-dihydroxy-l-phenylalanine (l-DOPA), that selectively forms a covalent linkage to the target protein. Such peptide-based probes can also be fused to tailored reporter proteins and easily expressed in bacterial cultures. As a demonstration, a candidate peptide, TOP1, that weakly binds to the target protein, the Src homology 3 (SH3) domain of human Abelson tyrosine kinase (Abl), was fused to green fluorescent protein (GFP) and l-DOPA was site-specifically incorporated into the peptide region (TOP1-DOPA-GFP). TOP1-DOPA-GFP produced from Escherichia coli was used in a Western blot-type experiment to show that the Abl SH3 domain can be detected in one step by observing the fluorescence. The molecular design presented in this work is significant in that the same approach could be used to transform many other protein-binding peptides with insufficient affinities into protein detection probes with a variety of fused reporter or therapeutic proteins.

Indexed as

Amino Acid SequenceBlotting, WesternCross-Linking ReagentsElectrophoresis, Polyacrylamide GelGreen Fluorescent ProteinsHumansLevodopaPeptidesProtein BindingProto-Oncogene Proteins c-ablRecombinant Fusion Proteinssrc Homology DomainsTwo-Hybrid System TechniquesCross-Linking ReagentsGreen Fluorescent ProteinsLevodopaPeptidesProto-Oncogene Proteins c-ablRecombinant Fusion Proteins

Identifiers

PMID20510935
PMCPMC2914685
OpenAlexW1986132307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.